• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Double-hit diffuse large B-cell lymphoma.

作者信息

Friedberg Jonathan W

机构信息

University of Rochester, Rochester, NY, USA.

出版信息

J Clin Oncol. 2012 Oct 1;30(28):3439-43. doi: 10.1200/JCO.2012.43.5800. Epub 2012 Sep 4.

DOI:10.1200/JCO.2012.43.5800
PMID:22949152
Abstract
摘要

相似文献

1
Double-hit diffuse large B-cell lymphoma.双打击弥漫性大B细胞淋巴瘤
J Clin Oncol. 2012 Oct 1;30(28):3439-43. doi: 10.1200/JCO.2012.43.5800. Epub 2012 Sep 4.
2
Immunohistochemical double-hit score is a strong predictor of outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone.免疫组化双打击评分是利妥昔单抗联合环磷酰胺、多柔比星、长春新碱和泼尼松治疗弥漫性大 B 细胞淋巴瘤患者预后的强有力预测指标。
J Clin Oncol. 2012 Oct 1;30(28):3460-7. doi: 10.1200/JCO.2011.41.4342. Epub 2012 Jun 4.
3
[Significance and application of c-myc in diffuse large B-cell lymphoma].c-myc在弥漫性大B细胞淋巴瘤中的意义及应用
Zhonghua Bing Li Xue Za Zhi. 2013 Sep;42(9):638-40.
4
Prognostic significance of MYC, BCL2, and BCL6 rearrangements in patients with diffuse large B-cell lymphoma treated with cyclophosphamide, doxorubicin, vincristine, and prednisone plus rituximab.弥漫性大 B 细胞淋巴瘤患者接受环磷酰胺、多柔比星、长春新碱和泼尼松联合利妥昔单抗治疗中 MYC、BCL2 和 BCL6 重排的预后意义。
Cancer. 2012 Sep 1;118(17):4173-83. doi: 10.1002/cncr.27396. Epub 2011 Dec 27.
5
[B-cell lymphomas with concurrent myc and bcl-2/IgH or bcl-6 translocations].伴有myc与bcl-2/IgH或bcl-6同时易位的B细胞淋巴瘤
Zhonghua Bing Li Xue Za Zhi. 2013 Sep;42(9):584-8.
6
Sole rearrangement but not amplification of MYC is associated with a poor prognosis in patients with diffuse large B cell lymphoma and B cell lymphoma unclassifiable.仅MYC基因重排而非扩增与弥漫性大B细胞淋巴瘤和无法分类的B细胞淋巴瘤患者的不良预后相关。
Br J Haematol. 2016 Nov;175(4):631-640. doi: 10.1111/bjh.14282. Epub 2016 Jul 29.
7
A blind skin biopsy diagnosing an intravascular large B-cell lymphoma.一次通过盲法皮肤活检诊断出血管内大B细胞淋巴瘤的病例。
Eur J Dermatol. 2011 Jan-Feb;21(1):114-5. doi: 10.1684/ejd.2010.1174.
8
Rearrangement of MYC is associated with poor prognosis in patients with diffuse large B-cell lymphoma treated in the era of rituximab.MYC 重排与利妥昔单抗时代治疗的弥漫性大 B 细胞淋巴瘤患者的不良预后相关。
J Clin Oncol. 2010 Jul 10;28(20):3360-5. doi: 10.1200/JCO.2009.26.3947. Epub 2010 May 24.
9
Prognostic impact of p53 aberrations for R-CHOP-treated patients with diffuse large B-cell lymphoma.p53 异常对接受 R-CHOP 治疗的弥漫性大 B 细胞淋巴瘤患者的预后影响。
Int J Oncol. 2011 Dec;39(6):1413-20. doi: 10.3892/ijo.2011.1170. Epub 2011 Aug 18.
10
Long-term remission of paroxysmal nocturnal hemoglobinuria following chemoimmunotherapy for non-Hodgkin lymphoma.非霍奇金淋巴瘤化疗免疫治疗后阵发性睡眠性血红蛋白尿长期缓解
Clin Adv Hematol Oncol. 2012 Feb;10(2):134-6.

引用本文的文献

1
Integrative genomic analysis of DLBCL identifies immune environments associated with bispecific antibody response.弥漫性大B细胞淋巴瘤的综合基因组分析确定了与双特异性抗体反应相关的免疫环境。
Blood. 2025 May 22;145(21):2460-2472. doi: 10.1182/blood.2024025355.
2
Double-hit primary central nervous system lymphoma with histogenetically proven bone marrow infiltration: a case report and a review of the literature.双打击原发性中枢神经系统淋巴瘤伴骨髓浸润的组织学证实：一例病例报告及文献复习。
Brain Tumor Pathol. 2024 Oct;41(3-4):145-150. doi: 10.1007/s10014-024-00490-z. Epub 2024 Aug 31.
3
Double-Expressor Appendiceal Burkitt's Lymphoma: A Case Report and Literature Review.
双表达阑尾伯基特淋巴瘤：一例报告及文献综述
Case Rep Hematol. 2022 Mar 25;2022:6795699. doi: 10.1155/2022/6795699. eCollection 2022.
4
Salvage radiotherapy for primary refractory and relapsed diffuse large B-Cell lymphoma.挽救性放疗用于原发性难治和复发性弥漫性大 B 细胞淋巴瘤。
Br J Radiol. 2021 Nov 1;94(1127):20210360. doi: 10.1259/bjr.20210360. Epub 2021 Aug 31.
5
Targeting PIN-1 Attenuates GCB DLBCL Cell Proliferation Through Inhibition of PI3K/AKT Signaling.靶向PIN-1通过抑制PI3K/AKT信号通路减弱生发中心B细胞样弥漫性大B细胞淋巴瘤细胞的增殖。
Onco Targets Ther. 2020 Aug 25;13:8593-8600. doi: 10.2147/OTT.S247429. eCollection 2020.
6
Venetoclax plus R- or G-CHOP in non-Hodgkin lymphoma: results from the CAVALLI phase 1b trial.维奈克拉联合 R-或 G-CHOP 方案治疗非霍奇金淋巴瘤：CAVALLI 期 1b 试验结果。
Blood. 2019 May 2;133(18):1964-1976. doi: 10.1182/blood-2018-11-880526. Epub 2019 Mar 8.
7
Dose-adjusted EPOCH-R (etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab) in untreated aggressive diffuse large B-cell lymphoma with MYC rearrangement: a prospective, multicentre, single-arm phase 2 study.剂量调整的EPOCH-R方案（依托泊苷、泼尼松、长春新碱、环磷酰胺、阿霉素和利妥昔单抗）用于治疗未经治疗的伴有MYC重排的侵袭性弥漫性大B细胞淋巴瘤：一项前瞻性、多中心、单臂2期研究。
Lancet Haematol. 2018 Dec;5(12):e609-e617. doi: 10.1016/S2352-3026(18)30177-7.
8
Isolated hypoglossal nerve palsy as a presenting symptom of metastatic peripheral T-cell lymphoma - not otherwise specified (PTCL-NOS): a unique case & a review of the literature.孤立性舌下神经麻痹作为转移性外周T细胞淋巴瘤（非特指型，PTCL-NOS）的首发症状：1例独特病例及文献复习
Int J Hematol Oncol. 2018 Jun 28;7(1):IJH03. doi: 10.2217/ijh-2018-0002. eCollection 2018 Mar.
9
Aggressive lymphoma 2016: revision of the WHO classification.2016年侵袭性淋巴瘤：世界卫生组织分类修订版
Memo. 2017;10(4):248-254. doi: 10.1007/s12254-017-0367-8. Epub 2017 Nov 30.
10
Double-Hit Large B Cell Lymphoma.双打击大 B 细胞淋巴瘤。
Curr Oncol Rep. 2017 Sep 26;19(11):74. doi: 10.1007/s11912-017-0629-y.